OSAM
TCRT icon

O'Shaughnessy Asset Management’s Alaunos Therapeutics TCRT Stock Holding History

O'Shaughnessy Asset Management’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-17
Closed -$5K – 2356
2021
Q3 		$5K Hold
17
– – ﹤0.01% 2346
2021
Q2 		$7K Hold
17
– – ﹤0.01% 2085
2021
Q1 		$9K Hold
17
– – ﹤0.01% 1810
2020
Q4 		$7K Hold
17
– – ﹤0.01% 1619
2020
Q3 		$7K Hold
17
– – ﹤0.01% 1441
2020
Q2 		$8K Buy
+17
New +$7.58K ﹤0.01% 1304
2020
Q1 		– Sell
-17
Closed -$12K – 1778
2019
Q4 		$12K Buy
+17
New +$11.7K ﹤0.01% 1262

Other funds holding TCRT

MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

O'Shaughnessy Asset Management's TCRT Position: Q4 2021 in Review

O'Shaughnessy Asset Management sold out of Alaunos Therapeutics (TCRT) in Q4 2021, closing a stake of 17 shares — an estimated $5K sold.

O'Shaughnessy Asset Management first reported a position in TCRT in Q4 2019 and held it in 7 quarters. The position peaked at $12K in Q4 2019. 165 funds tracked by Wall St. Rank hold TCRT as of Q4 2021.

  • O'Shaughnessy Asset Management reported no remaining Alaunos Therapeutics position as of Q4 2021 after selling out during the quarter.
  • O'Shaughnessy Asset Management sold 17 Alaunos Therapeutics shares in Q4 2021, an estimated $5K.
  • O'Shaughnessy Asset Management first reported a position in Alaunos Therapeutics in Q4 2019 and held it in 7 quarters.
  • O'Shaughnessy Asset Management's Alaunos Therapeutics position peaked at $12K in Q4 2019.
  • 165 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q4 2021.

Based on O'Shaughnessy Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.